Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07362082

A Clinical Trial of Telehealth Treatment for Opioid Use Disorders

This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Opioid Use Disorder Chemically-Induced Disorders Mental Disorders Narcotic-Related Disorders Opioid-Related Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale University

New Haven, Connecticut, 06520, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Can speak, read and write in English
  • Provision of signed and dated informed consent form
  • Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition
  • Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer)
  • Can provide a working email address OR be willing to create one

Exclusion criteria

  • Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
  • Pregnancy
  • Known current suicide risk based on participant self-report
  • On parole or incarcerated at time of enrollment based on participant self-report

Treatment and study plan

RecoveryPad platform

Device

Telehealth platform to enhance motivation and engagement in treatment for OUD

Primary outcomes

  1. Attendance for MOUD

    Time frame: Up to 30 days

    Overall attendance will be measured by attendance (yes or no) at the first MOUD appointment within 30 days of enrollment.

Secondary outcomes

  1. Attendance for MOUD

    Time frame: Up to 90 days

    Overall attendance will be measured by attendance (yes or no) at the first MOUD appointment within 31 to 90 days of enrollment.

  2. Engagement with MOUD

    Time frame: Up to 90 days

    Engagement will be measured by demonstrated maintained attendance with MOUD treatment within 90 days of enrollment.

  3. Overdose Events at 30 Days

    Time frame: Up to 30 days

    A self-report of the number of subsequent overdose events within 30 days.

  4. Overdose Events at 90 Days

    Time frame: Up to 90 days

    A self-report of the number of subsequent overdose events within 90 days.

Study contacts

Contact information is provided by the study sponsor or research team.

Rebekah Heckmann, MD

CONTACT

[email protected]

(203) 737-8335

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • City University of New York, School of Public Health
  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 23, 2026
Registry last updated
Jul 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.